Pharmafile Logo
Pharmafocus logo
Advanced Search

immunosuppresive

Showing 2 posts of 2 posts found.

abbvie_0

Abbvie acquires immune-oncology target from argenx

April 21, 2016
Research and Development, Sales and Marketing AbbVie, Protein, argenx, garp, immuno-oncology, immunosuppresive

AbbVie (NYSE:ABBV) has announced the acquisition of a new preclinical-stage human antibody program evaluating the novel immune-oncology target GARP, a …

News
jose_conejo-garcia_-_wistar_institute

Targeted cancer therapies can suppress T cell immune responses, study finds

March 23, 2016
Research and Development T cell, anti-cancer drugs, immunosuppresive, superagonist, wistar institute

Researchers at the Wistar Institute have developed a new method whereby targeted cancer therapies can provide appropriate therapeutics without supressing …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025